← Leaderboards
Lilly Yw Bourguignon
University Of Miami School Of Medicine
$5,233,104
Attributed
$5,233,104
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $797.5K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,233,104 · 3
VA$0 · 2
By mechanism
R01$5,050,323 · 2
P01$182,781 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Protein Isoforms”
- Randall J Bateman · Washington University$79,170,583
- Rolf Apweiler · European Molecular Biology Laboratory$41,336,566
- Stanley B Prusiner · University Of California San Francisco$33,187,893
- Howard Y Chang · Stanford University$26,252,541
- David A Bennett · Rush University Medical Center$25,855,566
- Yadong Huang · J. David Gladstone Institutes$24,532,318
Research focus
Protein IsoformsCytoskeletonNeoplastic ProcessSignaling MoleculeCd44 MoleculeNeoplastic CellHuman TissueEventImmunocytochemistrySignal TransductionMolecularCd44 GeneMediatingAnkyrinsPathway InteractionsMigrationExtracellular MatrixHyaluronanCd44 AntigensLaboratory RabbitSite Directed MutagenesisCell LineBinding (Molecular Function)Behavior
Grant awards (28)
Selective Hyaluronan Treatment to Overcome Age-related Epidermal Dysfunction$0
I01 · FY2015 · VA · contact PI
Selective Hyaluronan Treatment to Overcome Age-related Epidermal Dysfunction$0
I01 · FY2015 · VA · contact PI
Selective Hyaluronan Treatment to Overcome Age-related Epidermal Dysfunction$0
I01 · FY2015 · VA · contact PI
CD44 & Stem Cell Marker (Nanog) in Head and Neck Cancer$0
I01 · FY2014 · VA · contact PI
CD44 & Stem Cell Marker (Nanog) in Head and Neck Cancer$0
I01 · FY2013 · VA · contact PI
CD44 & Stem Cell Marker (Nanog) in Head and Neck Cancer$0
I01 · FY2012 · VA · contact PI
CD44 & Stem Cell Marker (Nanog) in Head and Neck Cancer$0
I01 · FY2011 · VA · contact PI
CD44/Variant Cytoskeleton in Breast Cancer Progression$243,832
R01 · FY2010 · CA · contact PI
CD44/Variant Cytoskeleton in Breast Cancer Progression$243,832
R01 · FY2009 · CA · contact PI
CD44/Variant Cytoskeleton in Breast Cancer Progression$243,832
R01 · FY2008 · CA · contact PI
CD44-p185HER2 Interaction in Ovarian Cancer Progression$370,897
R01 · FY2007 · CA · contact PI
CD44/Variant Cytoskeleton in Breast Cancer Progression$243,832
R01 · FY2007 · CA · contact PI
Project 2$182,781
P01 · FY2007 · AR · contact PI
CD44-p185HER2 Interaction in Ovarian Cancer Progression$371,348
R01 · FY2006 · CA · contact PI
CD44/Variant Cytoskeleton in Breast Cancer Progression$251,114
R01 · FY2006 · CA · contact PI
CD44-p185HER2 Interaction in Ovarian Cancer Progression$369,724
R01 · FY2005 · CA
CD44-p185HER2 Interaction in Ovarian Cancer Progression$330,037
R01 · FY2004 · CA
CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION$256,238
R01 · FY2004 · CA
CD44-p185HER2 Interaction in Ovarian Cancer Progression$320,424
R01 · FY2003 · CA
CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION$228,777
R01 · FY2003 · CA
CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION$335,409
R01 · FY2002 · CA
CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION$256,373
R01 · FY2002 · CA
CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION$310,860
R01 · FY2001 · CA
CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION$225,317
R01 · FY2001 · CA
CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION$7,362
R01 · FY2001 · CA
CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION$6,966
R01 · FY2001 · CA
CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION$225,832
R01 · FY2000 · CA
CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION$208,317
R01 · FY2000 · CA